Table 1 The association of the expression of CD59 with the clinicopathological features from ESCC patients (n = 80)
CD59 | P | ||
|---|---|---|---|
Low level | High level | ||
Age | 0.303 | ||
<60 | 24 | 23 | |
≥60 | 13 | 20 | |
Gender | 0.363 | ||
Male | 30 | 38 | |
Female | 7 | 5 | |
Stage | 0.713 | ||
I–II | 17 | 18 | |
III–IV | 20 | 25 | |
CD59 | P | ||
|---|---|---|---|
Low level | High level | ||
Age | 0.303 | ||
<60 | 24 | 23 | |
≥60 | 13 | 20 | |
Gender | 0.363 | ||
Male | 30 | 38 | |
Female | 7 | 5 | |
Stage | 0.713 | ||
I–II | 17 | 18 | |
III–IV | 20 | 25 | |